Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.94 |
| ▸ | CA1 | P00915 | 4/20 | 0.94 |
| ▸ | CA2 | P00918 | 4/20 | 0.94 |
| ▸ | CA7 | P43166 | 4/20 | 0.94 |
| ▸ | CA9 | Q16790 | 4/20 | 0.94 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.94 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.94 |
| ▸ | MAPT | P10636 | 3/20 | 0.94 |
| ▸ | CA4 | P22748 | 3/20 | 0.94 |
| ▸ | CA6 | P23280 | 3/20 | 0.94 |
| ▸ | LMNA | P02545 | 3/20 | 0.94 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.94 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.94 |
| ▸ | FUT7 | Q11130 | 2/20 | 0.94 |
| ▸ | CA3 | P07451 | 2/20 | 0.94 |
| ▸ | CA5A | P35218 | 2/20 | 0.94 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.94 |
| ▸ | TP53 | P04637 | 1/20 | 0.94 |
| ▸ | SELL | P14151 | 1/20 | 0.94 |
| ▸ | HPGD | P15428 | 1/20 | 0.94 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gallic Acid SCHEMBL11242130 | 1.00 | CA12 (0.94) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL27661465 | 0.97 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL28045480 | 0.97 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL27758718 | 0.97 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL4276875 | 0.97 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL28704043 | 0.97 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL28331287 | 0.97 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL3137007 | 0.97 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL15012 | 0.97 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL4918056 | 0.97 | CA12 (1.00) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 456 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024022447-A1 | USE OF BISMUTH-POLYMER COMPLEX IN DIGESTIVE TRACT VISUALIZATION | 上海交通大学 | 2024-02-01 | — | — | WO | claimed |
| WO-2023063827-A1 | SYNERGISTIC COMPOSITION AGAINST PSEUDOMONAS AERUGINOSA | OMNICIN THERAPEUTICS B.V. (NL) | 2023-04-20 | — | — | WO | claimed |
| CN-112267306-A | Flame-retardant anti-static fabric and preparation method thereof | 李东靖 | 2021-01-26 | — | — | CN | claimed |
| US-20200268769-A1 | METHODS FOR TREATING HELICOBACTER INFECTION | DEXCEL PHARMA TECHNOLOGIES LTD. (IL) | 2020-08-27 | — | — | US | claimed |
| EP-3036194-B1 | OPTICAL COMPOUNDS, USE AND METHOD FOR PRODUCING THEREOF | BEP S R L (IT) | 2019-03-27 | — | — | EP | claimed |
| CN-108325054-A | Intra-cavity treatment system for gastrointestinal tract infection | 刘泰成 | 2018-07-27 | — | — | CN | claimed |
| CN-107602897-A | A kind of preparation method of gallic acid bismuth structure ferroelectric thin-flim materials | 苏州云舒新材料科技有限公司 | 2018-01-19 | — | — | CN | claimed |
| US-9816029-B2 | Organic amine decarbonization solutions | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2017-11-14 | — | — | US | claimed |
| EP-2768936-B1 | FORMULATIONS, THEIR USE AS OR FOR THE MANUFACTURE OF DISHWASHING COMPOSITIONS, AND MANUFACTURE | BASF SE (DE) | 2017-03-01 | — | — | EP | claimed |
| WO-2016203431-A1 | LUMINESCENT BISMUTH SILICATES, USE AND METHOD FOR PRODUCING THEREOF | UNIVERSITA' CA' FOSCARI (IT) | 2016-12-22 | — | — | WO | claimed |
| US-6436201-B1 | RUST PROOFING UNTREATED STEEL PLATES OR SHEETS; RESIN SUCH AS AMINE ADDED EPOXY RESIN; BISMUTH, LANTHANUM OR MOLYBDENUM COMPOUND; MAGNESIUM OR ZINC ALUMINUM HYDROXIDE HYDRATE; SMOOTHNESS; LEAD AND CHROMIUM FREE; AUTOMOBILE UNDERCOATINGS | KANSAI PAINT CO., LTD. (JP) | 2002-08-20 | — | — | US | claimed |
| US-20020068836-A1 | Reaction systems for making N- (phosphonomethyl) glycine compounds | MONSANTO COMPANY | 2002-06-06 | — | — | US | claimed |
| US-20020016503-A1 | Use of a supplemental promoter in conjunction with a carbon-supported, noble-metal containing catalyst in liquid phase oxidation reactions | MONSANTO TECHNOLOGY LLC | 2002-02-07 | — | — | US | claimed |
| WO-2001092272-A2 | REACTION SYSTEMS FOR MAKING N-(PHOSPHONOMETHYL)GLYCINE COMPOUNDS | MONSANTO TECHNOLOGY LLC (US) | 2001-12-06 | — | — | WO | claimed |
| EP-0910393-B1 | AGENT FOR THE TOPICAL TREATMENT OF SKIN CONDITIONS | LUFEN HANS (DE) | 2001-12-05 | — | — | EP | claimed |
| WO-2001046208-A2 | USE OF A SUPPLEMENTAL PROMOTER IN CONJUNCTION WITH A CARBON-SUPPORTED, NOBLE-METAL-CONTAINING CATALYST IN LIQUID PHASE OXIDATION REACTIONS | MONSANTO TECHNOLOGY LLC (US) | 2001-06-28 | — | — | WO | claimed |
| CN-1124136-A | Apparatus and process for strengthening low density compression dosage units and product therefrom | FUISZ TECHNOLOGIES LTD (US) | 1996-06-12 | — | — | CN | claimed |
| US-5035973-A | Image forming method and apparatus therefor | KABUSHIKI KAISHA TOSHIBA (JP) | 1991-07-30 | — | — | US | claimed |
| US-4670245-A | ULCERS | VASQUEZ TONY E | 1987-06-02 | — | — | US | claimed |
| US-4298003-A | System for delivering agent at zero order rate with emerging agent below saturation | ALZA CORPORATION (US) | 1981-11-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020016503-A1 | Use of a supplemental promoter in conjunction with a carbon-supported, noble-metal containing catalyst in liquid phase oxidation reactions | GNMT, OGG1, NT5C3B | CA12 1421/4885CA1 99/4885CA2 229/4885 |
| US-20020068836-A1 | Reaction systems for making N- (phosphonomethyl) glycine compounds | GNMT, NPM1, OGA | CA12 1027/4885CA1 730/4885CA2 626/4885 |
| US-20200268769-A1 | METHODS FOR TREATING HELICOBACTER INFECTION | FUS, SI, NSF | CA12 570/4885CA1 1262/4885CA2 929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.